Feb07

Health Blog Video: Roche CEO on the Illumina Bid

Roche CEO Severin Schwan says the offer of $44.50 per share for Illumina is “attractive” and “represents full and fair value.”

Feb07

Komen Foundation VP resigns after funding controversy

Karen Handel, a vice president with the Susan G. Komen for the Cure Foundation, resigned her position Tuesday following a controversy over funding for Planned Parenthood projects, the foundation said.

Feb07

How to Avoid Deep-Vein Thrombosis on Long Flights

The guidelines agree with previous studies that first-class and business-class passengers are at risk, too.

Feb07

Obama to boost Alzheimer’s research funding

The Obama administration will push for a $156 million increase in funding for Alzheimer's research over the next two years, the Department of Health and Human Services announced Tuesday.

Feb07

Susan G. Komen for the Cure Official Handel Quits

Handel says she thought the decision to end funding to Planned Parenthood because it was the subject of a congressional investigation was the right one.

Feb07

Health Journal: Deciphering the Ailments Tied to Gluten

A fundamental mystery is why gluten, a staple of most human diets since the dawn of agriculture 10,000 years ago, is creating more health problems now.

Feb07

A.M. Vitals: Merck Will Apply for Suvorexant Approval This Year

Also: eating on campus; cancer in dogs; Weight Watchers and Points Plus.

Feb07

Georgia’s child obesity ads aim to create movement out of controversy

Georgia’s controversial child obesity ads are being phased out, but debate continues over whether they do more harm than good.